ASHP statement on the pharmacist's role in clinical pharmacogenomics

American Journal of Health-System Pharmacy

Volumn 72, Issue 7, 2015, Pages 579-581

  Haidar, Cyrine Eliana ^a   Hoffman, James M ^a   Johnson, Samuel G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PHARMACY; CONSENSUS; DECISION MAKING; GENETIC VARIATION; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; LABORATORY PERSONNEL; LEADERSHIP; PATIENT CARE; PATIENT SAFETY; PHARMACIST; PHARMACOGENOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPONSIBILITY; TREATMENT DURATION; CLINICAL DECISION SUPPORT SYSTEM; COOPERATION; DOCUMENTATION; DRUG THERAPY; GENETIC SCREENING; HEALTH CARE ORGANIZATION; MANPOWER; PATIENT EDUCATION; PHARMACOGENETICS; PROFESSIONAL STANDARD; UNITED STATES;

COOPERATIVE BEHAVIOR; DECISION SUPPORT SYSTEMS, CLINICAL; DOCUMENTATION; DRUG THERAPY; GENETIC TESTING; HUMANS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PHARMACOGENETICS; PROFESSIONAL ROLE; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 84975877985     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/sp150003     Document Type: Article

References (13)

1. Swen JJ, Nijenhuis M, de Boer A et al. Pharmacogenetics: from bench to byte - an update of guidelines. Clin Pharmacol Ther. 2011; 89(5):662-73.
2. Manolio TA, Chisholm RL, Ozenberger B et al. Implementing genomic medicine in the clinic: the future is now. Genet Med. 2013; 15(4):258-67.
3. Wu AC, Fuhlbrigge AL. Economic evaluation of pharmacogenetic tests. Clin Pharmacol Ther. 2008; 84(2):272-4.
4. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011; 89(3):464-7.
5. ASHP policy position 1104: Pharmacogenomics. In: Hawkins B, ed. Best practices for hospital and health-system pharmacy: positions and guidance documents of ASHP. 2013-2014 ed. Bethesda, MD: American Society of Health-System Pharmacists; 2013:162. http://www.ashp.org/DocLibrary/BestPract ices/FormularyPositions.aspx (accessed 2014 Jun 19).
6. Table of Pharmacogenomic Biomarkers in Drug Labeling. http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm (accessed 2014 Jun 19).
7. Clinical Pharmacogenetics Implementation Consortium [CPIC]. Drug-Gene Pairs. www.pharmgkb.org/page/cpic GeneDrugPairs (accessed 2014 Jun 19).
8. American Society of Health-System Pharmacists. Endorsed Documents. http://www.ashp.org/menu/PracticePolicy/PolicyPositionsGuidelinesBestPractices/BrowsebyDocumentType/Endorsed Documents.aspx (accessed 2014 Jun 19).
9. Feero WG, Kuo GM, Jenkins JR et al. Pharmacist education in the era of genomic medicine. J Am Pharm Assoc. 2012; 52:e113-e121.
10. Hicks JK, Crews KR, Hoffman JM et al. A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharmacol Ther. 2012; 92(5):563-6.
11. Welch BM, Kawamoto K. Clinical decision support for genetically guided personalized medicine: a systematic review. J Am Med Inform Assoc. 2013; 20(2):388-400.
12. Pulley JM, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther. 2012; 92(1):87-95.
13. Bell GC, Crews KR, Wilkinson MR et al. Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc. 2013. DOI: 10.1136/anuajnl-2013-001993 [Epub ahead of print].